SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-21-056803
Filing Date
2021-11-04
Accepted
2021-11-04 17:17:50
Documents
7
Period of Report
2021-11-03
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea149991-8k_oramed.htm 8-K 25735
2 ENGAGEMENT LETTER, DATED AS OF NOVEMBER 2, 2021, BETWEEN THE COMPANY AND H.C. WA ea149991ex1-1_oramed.htm EX-1.1 47878
3 OPINION OF SULLIVAN & WORCESTER LLP ea149991ex5-1_oramed.htm EX-5.1 11451
4 FORM OF SECURITIES PURCHASE AGREEMENT, DATED AS OF NOVEMBER 3, 2021 BETWEEN THE ea149991ex10-1_oramed.htm EX-10.1 188022
5 GRAPHIC ex1-1_001.jpg GRAPHIC 7343
6 GRAPHIC ex5-1_001.jpg GRAPHIC 6070
7 GRAPHIC ex5-1_002.jpg GRAPHIC 1755
  Complete submission text file 0001213900-21-056803.txt   295731
Mailing Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036
Business Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036 646-844-1164
ORAMED PHARMACEUTICALS INC. (Filer) CIK: 0001176309 (see all company filings)

IRS No.: 980376008 | State of Incorp.: DE | Fiscal Year End: 0831
Type: 8-K | Act: 34 | File No.: 001-35813 | Film No.: 211381158
SIC: 2834 Pharmaceutical Preparations